Tandem Diabetes Care Announces First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Buildings collapse as quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Tandem Diabetes (TNDM) Misses Q1 EPS by 8c, Revenues Beat; Provides 2Q Revenue Outlook, Withdraws FY20 Guidance
April 30, 2020 4:51 PM EDTTandem Diabetes (NASDAQ: TNDM) reported Q1 EPS of ($0.25), $0.08 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $97.9 million versus the consensus estimate of $84.46 million.
In comparing the first quarter of 2020 to the same period of 2019:
Worldwide pump shipments increased 18 percent to 17,378 pumps from 14,732 pumpsSales increased 48 percent to $97.9 million from $66.0 millionGross margin for both... More